Around the Web

Cancer News

Brachytherapy is an efficient treatment for numerous cancer diseases. To support this, the Cancer News regularly inform about related studies and articles as well as cancer demographics. Subscribe to our newsletter to receive the latest news first:
Subscription Cancer News
* Mandatory fields

March 03, 2016

Effect of socioeconomic position on survival after childhood cancer in Denmark

Background: One fifth of all deaths among children in Europe are accounted for by cancer. If this is to be reduced there is a need for studies on not only biology and treatment approaches but also on how social factors influence cure rates...

Read More

February 28, 2016

Why we should care about standards of care?

“Standard of care” (SOC) is a legalistic term. As it applies to medicine, wh en a clinician follows an SOC, it means that he or she has proceeded with the reasonable caution that any minimally competent doctor would and should exercise in such circumstances...

Read More

February 24, 2016

Breast cancer 'first response' at 10-year low

The proportion of women in England taking up their initial invitation for breast cancer screening is at its lowest level in a decade, figures show. The Health and Social Care Information Centre data showed the proportion of women aged 50-70 screened fell to 63.3% in 2014-15, from 70.1% in 2004-05. Breast screening coverage - the overall number checked - has also fallen for the fourth year in a row...
Read more

February 24, 2016

Medicaid, uninsured patients experience worse head and neck cancer outcomes

Uninsured patients and those with Medicaid appeared more likely to present with advanced stages of head and neck cancers and to have inferior outcomes than those who have other forms of insurance, according to study results presented at the Multidisciplinary Head and Neck Cancer Symposium...
Read More

February 23, 2016

Defining the Value Framework for Prostate Brachytherapy using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing

PURPOSE: Value, defined as outcomes over costs, has been proposed as a measure to evaluate prostate cancer (PCa) treatments. We analyzed standardized outcomes and time-driven activity-based costing (TDABC) for prostate brachytherapy (PBT) to define a value framework...

Read More

February 10, 2016

Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic

Prostate cancer is highly prevalent in Jamaica and is the leading cause of cancer-related deaths. Our aim was to evaluate the patterns of screening in the largest organized screening clinic in Jamaica at the Jamaica Cancer Society...
Read More

January 29, 2016

Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer

We report clinical observations of a technique using an MRI-only workflow for catheter insertion and treatment planning in patients receiving standard-care high-dose-rate brachytherapy before external beam radiotherapy for prostate cancer...
Read More

January 29, 2016

Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes

To compare rectal toxicity, urinary toxicity, and nadir+2 PSA relapse-free survival (bRFS) in two consecutive Phase II protocols of high-dose-rate (HDR) brachytherapy used at the authors institution from 2001 to 2012...
Read More

January 22, 2016

High dose rate brachytherapy for prostate cancer: Standard of care and future direction

Abstract: High dose rate brachytherapy is a highly conformal method of radiation dose escalation for prostate cancer and one of several treatment options for men with localised disease. The large doses per fraction exploit the low alpha/beta ratio of prostate cancer cells so that biological radiation dose delivered is substantially greater than that achieved with conventional external beam delivery...
Read More

January 12, 2016

US panel finalizes breast cancer screening recommendations

An influential panel of U.S. experts issued final recommendations on Monday reaffirming their controversial position that mammogram screening should start at age 50, but also said some women may benefit from screening starting at age 40...

Read More

January 11, 2016

As number of cancer survivors grows, so does rate of second malignancies

There are approximately 14.5 million cancer survivors in the United States, according to the American Cancer Society. That number is expected to climb to nearly 19 million by 2024, the society estimates. Although advances in early detection and treatment have dramatically increased the likelihood that Americans will survive their initial cancer diagnosis...
Read More

Displaying results 51 to 61 out of 61
<< First < Previous 1-50 51-61 Next > Last >>

Search in Cancer News

GEC-ESTRO Brachytherapy Guidelines:


ABS Brachytherapy Guidelines and Consensus Statements: